SWOT Analysis for Pacira BioSciences Inc

30 Day SMA crossing over 200 Day SMA, and current price greater than open
Turnaround Potential (DVM)
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
Weekly Strategy: High Momentum Score Stocks (subscription)
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Negative to Positive growth in Sales and Profit with Strong Price momentum
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Recent Results: Declining Operating Profit Margin and Net Profits (YoY)

Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months